Skip to main content
Upendra Parvathaneni, MD, Radiation Oncology, Seattle, WA

UpendraParvathaneniMDFRANZCR

Radiation Oncology Seattle, WA

Head & Neck, Skin Cancer

Associate Professor, Chief of Head and Neck Radiation Oncology Program, Head of Neutron Radiation Treatment program, University of Washington

Dr. Parvathaneni is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Parvathaneni's full profile

Already have an account?

  • Office

    1959 NE Pacific St
    Seattle, WA 98195
    Phone+1 206-598-4100

Education & Training

  • University of Texas M.D. Anderson Cancer Center
    University of Texas M.D. Anderson Cancer Center2005 - 2006
  • Residency program of Royal Australian and New Zealand College of Radiologists
    Residency program of Royal Australian and New Zealand College of RadiologistsFRANZCR, 1998 - 2003
  • Rajah Muthiah Medical College
    Rajah Muthiah Medical CollegeClass of 1993

Certifications & Licensure

  • WA State Medical License
    WA State Medical License 2006 - 2026
  • American Board of Radiology Radiation Oncology
  • Fellow of Royal Australian and New Zealand College of RadiologistsRadiation Oncology

Awards, Honors, & Recognition

  • Annual Faculty Teaching Award University of Washington, Department of Radiation Oncology, 2007
  • Best Outgoing Student Annamalai University, 1993
  • First rank in Preclinical Subjects Annamalai University, 1988

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Patterns of Cervical Node Positivity, Regional Failure Rates, and Fistula Rates for HPV+ Oropharyngeal Squamous Cell Carcinoma Treated with Transoral Robotic Surgery (...  
    Jeffrey J Houlton, Sapna Patel, Upendra Parvathaneni, Eduardo Mendez, Neal D Futran, ScienceDirect
  • Intratumoral G100, a TLR4 Agonist, Induces Anti-Tumor Immune Responses and Tumor Regression in Patients with Merkel Cell Carcinoma  
    Upendra Parvathaneni, David M Koelle, David Byrd, Shailender Bhatia, Michi Shinohara, Clinical Cancer Research
  • A Novel Single-fraction Radiotherapy approach for metastatic Merkel cell carcinoma is well tolerated and demonstrates strong efficacy linked to intact cellular immunity  
    Parvathaneni U, Iyer J, Miller N, et al., Int J Radiat Oncol Phys Biol 90 (1) S758, 2014, 9/2014
  • Join now to see all

Books/Book Chapters

Professional Memberships

Other Languages

  • Hindi, Tamil, Telugu